IRRAS acquires medical device assets from DermaPort and partners with AMI-USC

IRRAS AB acquired assets and intellectual property from DermaPort, Inc., associated with AMI-USC, including complementary medical device technology for neurocritical care. IRRAS also established a collaborative relationship with AMI-USC.

“IRRAS will acquire assets and intellectual property from DermaPort, Inc., a development stage company associated with the AMI-USC, that include innovative access technology that is complementary to IRRAS’ core neurocritical care business.”news.cision.com

• 1 source
• news.cision.comIRRAS Establishes Collaborative Relationship with AMI-USC Through Acquisition of Complementary Medical Device Technology - IRRASApr 23, 2019

Summarized from public sources; check the original articles before acting on it.